Extended Data Table 1 Clinical and histopathological characteristics of the TRACERx 421 cohort

From: The evolution of non-small cell lung cancer metastases in TRACERx

  1. Comparison of baseline clinical and histopathological characteristics of patients who develop recurrent disease versus those who do not. All significant (p < 0.05) results are shown in red with corresponding statistical tests used. All tests performed were two-sided. F: Female, M: Male; ECOG, Eastern Cooperative Oncology Group performance status.
Back to article page